WallStreetZen

NASDAQ: MRNA
Moderna Inc Stock

$434.46+6.75 (+1.58%)
Updated Sep 15, 2021
MRNA Price
$434.46
Fair Value Price
$447.46
Market Cap
$175.37B
52 Week Low
$63.64
52 Week High
$497.49
P/E
50x
P/B
26.16x
P/S
13.46x
PEG
1.95x
Dividend Yield
N/A
Revenue
$7.02B
Earnings
$3.49B
Gross Margin
86.5%
Operating Margin
54.41%
Profit Margin
49.8%
Debt to Equity
1.41
Operating Cash Flow
$9B
Beta
0.22
Next Earnings
Oct 27, 2021
Ex-Dividend
N/A
Next Dividend
N/A

MRNA Overview

Zen Score

High
Medium
Low
45
Industry average

Reasons for this score

MRNA ($434.46) is undervalued by 2.91% relative to our estimate of its Fair Value price of $447.46 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
MRNA ($434.46) is trading below its intrinsic value of $843.87, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MRNA is good value based on its earnings relative to its share price (50x), compared to the US market average -8.74x)
Valuation

1 of 9

MRNA News

Valuation

MRNA fair value

Fair Value of MRNA stock based on Discounted Cash Flow (DCF)
Price
$434.46
Fair Value
$447.46
Undervalued by
2.91%
MRNA ($434.46) is undervalued by 2.91% relative to our estimate of its Fair Value price of $447.46 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
MRNA ($434.46) is trading below its intrinsic value of $843.87, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation

MRNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
50x
Industry
280.41x
Market
-8.74x
MRNA is good value based on its earnings relative to its share price (50x), compared to the US market average -8.74x)
Valuation
MRNA is good value based on its earnings relative to its share price (50x), compared to the US Biotechnology industry average (280.41x)
Valuation

MRNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
26.16x
Industry
6.98x
MRNA is poor value based on its book value relative to its share price (26.16x), compared to the US Biotechnology industry average (6.98x)
Valuation

MRNA price to earnings growth (PEG)

For valuing profitable companies with growth potential
MRNA is poor value relative to its rate of earnings growth, measured by PEG ratio (1.95x)
Valuation

MRNA's financial health

Profit margin

Revenue
$4.4B
Net Income
$2.8B
Profit Margin
63.8%
MRNA's Earnings (EBIT) of $3.82B can safely cover interest payments on company debt ($433.00M)
Financials
MRNA's profit margin has increased (+509.3%) in the last year from (-459.5%) to (49.8%)
Financials

Assets to liabilities

Assets
$16.2B
Liabilities
$9.4B
Debt to equity
0.06
MRNA's short-term assets ($10.97B) exceed its short-term liabilities ($8.84B)
Financials
MRNA's short-term assets ($10.97B) exceed its long-term liabilities ($609.00M)
Financials
MRNA's debt to equity ratio (1.41) is considered high
Financials

Cash flow

Operating
$4.1B
Investing
-$3.9B
Financing
-$24.0M
MRNA's operating cash flow ($9.19B) is sufficient to service the company's debt ($433.00M)
Financials

Moderna Stock FAQ

What is Moderna's quote symbol?

(NASDAQ: MRNA) Moderna trades on the NASDAQ under the ticker symbol MRNA. Moderna stock quotes can also be displayed as NASDAQ: MRNA.

What is the 52 week high and low for Moderna (NASDAQ: MRNA)?

(NASDAQ: MRNA) Moderna's 52-week high was $497.49, and its 52-week low was $63.64. It is currently -12.67% from its 52-week high and 582.68% from its 52-week low.

How much is Moderna stock worth today?

(NASDAQ: MRNA) Moderna currently has 403,646,312 outstanding shares. With Moderna stock trading at $434.46 per share, the total value of Moderna stock (market capitalization) is $175.37B.

Moderna stock was originally listed at a price of $18.60 in Dec 7, 2018. If you had invested in Moderna stock at $18.60, your return over the last 2 years would have been 2,235.81%, for an annualized return of 383.3%.

How much is Moderna's stock price per share?

(NASDAQ: MRNA) Moderna stock price per share is $434.46 today (as of Sep 15, 2021).

What is Moderna's Market Cap?

(NASDAQ: MRNA) Moderna's market cap is $175.37B, as of Sep 16, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Moderna's market cap is calculated by multiplying MRNA's current stock price of $434.46 by MRNA's total outstanding shares of 403,646,312.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.